Monday, October 26, 2020
Home Life Style Health & Fitness Research: Japan Scientists to Use 'Reprogrammed' Stem Cells to Fight Parkinson's

Research: Japan Scientists to Use ‘Reprogrammed’ Stem Cells to Fight Parkinson’s

The fact that the clinical trial uses iPS cells rather than human embryonic cells means the treatment would be acceptable in countries such as Ireland and much of Latin America, where embryonic cells are banned

Japanese scientists said Monday they will start clinical trials next month on a treatment for Parkinson’s disease, transplanting “reprogrammed” stem cells into brains, seeking a breakthrough in treating the neurodegenerative disorder.

Parkinson’s is caused by a lack of dopamine made by brain cells, and researchers have long hoped to use stem cells to restore normal production of the neurotransmitter chemical.

The clinical trials come after researchers at Japan’s Kyoto University successfully used human-induced pluripotent stem cells (iPS) to restore functioning brain cells in monkeys last year.

So-called iPS cells are made by removing mature cells from an individual — often from the skin or blood — and reprogramming them to behave like embryonic stem cells. They can then be coaxed into dopamine-producing brain cells.

Parkinsons
Parkinson’s is caused by a lack of dopamine made by brain cells. (IANS)

“This will be the world’s first clinical trial using iPS cells on Parkinson’s disease,” Jun Takahashi, professor at Kyoto University’s Centre for iPS Cell Research and Application, told a news conference.

The center is headed by Shinya Yamanaka, who in 2012 shared a Nobel Prize for medicine with a British scientist, John Gurdon, for the discovery that adult cells can be transformed back into embryo-like cells.

Also Read: Boxing for Fitness Takes the Fight to Parkinson’s Disease

“We intend to carry on conducting our research carefully, yet expeditiously, in coordination with Kyoto University Hospital, so that new treatment using iPS cells will be brought to patients as soon as possible,” Yamanaka said in a statement.

The fact that the clinical trial uses iPS cells rather than human embryonic cells means the treatment would be acceptable in countries such as Ireland and much of Latin America, where embryonic cells are banned. (VOA)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,779FollowersFollow

Most Popular

Here are Some Curated Gifts for the Festive Season

The onset of festive season sets in place an atmosphere bustling with joy, togetherness, lights and of course, gifts. It is undoubtedly the most...

Supplement without Testing Vitamin D and B12 Can Be Harmful

A blood test can determine whether you are deficient in any vitamins or not. Many people self-medicate or take dietary supplements for vitamin deficiencies....

COVID Interventions Can Reduce Infection Rates: Study

Non-pharmaceutical interventions such as voluntary shelter-in-place, quarantines, and other steps taken to control the novel coronavirus can reduce the peak number of infections, daily...

Few Steroids Boost Survival of Premature Babies in India: WHO

Antenatal steroids such as dexamethasone, used to treat many conditions, including rheumatic problems and severe COVID-19, can boost the survival of premature babies when...

Enterprises to Put Artificial Intelligence to New Frontiers in 2021

In 2021, one in four forward-thinking enterprises will push Artificial Intelligence to new frontiers, such as holographic meetings for remote work and on-demand personalised...

A Temple in Kanpur Worships Ravan on Dusshera

Even as the rest of India prepares to burn effigies of Ravan as a symbolic victory of good over evil, devotees are quietly lining...

Researchers Discover New Mechanism Causing Alzheimer’s Disease

Japanese researchers have discovered a new mechanism by which clumps of tau protein -- found in brain cells -- are created in the brain,...

New Model Predicts Risks of Developing Irregular Heartbeat

A new model that uses machine learning, which is a type of artificial intelligence, may help predict which patients with kidney disease are at...

Recent Comments